医学
乳腺癌
肿瘤科
内科学
化疗
孕酮受体
癌症
雌激素受体
妇科
雌激素受体
作者
Ke Liu,Guiping Chen,Xueqin Chen,San‐Gang Wu
标识
DOI:10.1080/14737140.2024.2393749
摘要
Not all eligible breast cancer (BC) patients could afford the expensive test of 21-gene recurrence score (RS) assay. This study aimed to identify clinicopathological factors associated with high-risk RS and examine whether these factors correlate with the benefit of chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI